|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,319 GBX | +0.61% |
|
+1.72% | +16.11% |
| 07-17 | AstraZeneca's Capivasertib Gets UK Marketing Authorization for Advanced Breast Cancer Treatment | MT |
| 07-17 | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
Attachments
Disclaimer
AstraZeneca plc published this content on 09 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 January 2023 07:08:14 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.11% | 247B | |
| +55.35% | 815B | |
| +32.14% | 597B | |
| -0.10% | 377B | |
| +15.47% | 319B | |
| +13.10% | 310B | |
| +14.94% | 228B | |
| +16.54% | 180B | |
| +4.31% | 170B | |
| +2.72% | 126B |
ASTRAZENECA PLC 
